XML 53 R37.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Stock based Compensation (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract] |
Schedule of Fair Value of Options | The fair value of the stock options granted were estimated on the date of grant using a Black-Scholes option pricing model with the following weighted-average assumptions:
|  | Years ended December 31,
|  | 2024 |  | 2023 |  | 2022
Expected stock price volatility |  | 57.0 | % |  | 59.2 | % |  | 62.1 | %
Risk free interest rate |  | 4.0 | % |  | 3.9 | % |  | 1.7 | %
Expected life of options (years) |  | 5.60 |  | 5.47 |  | 5.34
Expected annual dividend per share |  | $ | — |  |  | $ | — |  |  | $ | — |
Schedule of Stock Options Activity | A summary of the Company's stock options is as follows:
| Number of Shares |  | Weighted Average Exercise Price |  | Weighted Average Remaining Years |  | Aggregate Intrinsic Value
| (in thousands) |  |  |  |  |  | (in millions)
Options outstanding, December 31, 2021 | 14,731 |  |  | $ | 11.08 |  |  |  |  |
Granted | 5,733 |  |  | $ | 11.53 |  |  |  |  |
Exercised | (660) |  |  | $ | 6.58 |  |  |  |  |
Forfeited | (495) |  |  | $ | 12.57 |  |  |  |  |
Expired | (245) |  |  | $ | 12.84 |  |  |  |  |
Options outstanding, December 31, 2022 | 19,064 |  |  | $ | 11.31 |  |  |  |  |
Granted | 5,733 |  |  | $ | 11.99 |  |  |  |  |
Exercised | (1,361) |  |  | $ | 7.54 |  |  |  |  |
Forfeited | (356) |  |  | $ | 11.59 |  |  |  |  |
Expired | (78) |  |  | $ | 15.09 |  |  |  |  |
Options outstanding, December 31, 2023 | 23,002 |  |  | $ | 11.69 |  |  |  |  |
Granted | 4,917 |  |  | $ | 13.52 |  |  |  |  |
Exercised | (957) |  |  | $ | 8.02 |  |  |  |  |
Forfeited | (622) |  |  | $ | 12.75 |  |  |  |  |
Expired | (327) |  |  | $ | 14.30 |  |  |  |  |
Options outstanding, December 31, 2024 | 26,013 |  |  | $ | 12.11 |  |  | 5.8 |  | $ | 5.8 |
Vested and unvested expected to vest, December 31, 2024 | 24,643 |  |  | $ | 12.09 |  |  | 5.7 |  | $ | 5.8 |
Exercisable at December 31, 2024 | 17,464 |  |  | $ | 11.80 |  |  | 4.6 |  | $ | 5.7 |
Schedule of Non-Vested RSU Activity under the Plan | A summary of non-vested RSU activity under the Plan is as follows:
| Number of Shares |  | Weighted Average Grant Date Fair Value |  | Weighted Average Remaining Years |  | Aggregate Intrinsic Value
| (in thousands) |  |  |  |  |  | (in millions)
Non-vested units as of December 31, 2021 | 7,341 |  |  | $ | 13.90 |  |  |  |  |
Granted | 5,048 |  |  | $ | 11.93 |  |  |  |  |
Vested | (2,251) |  |  | $ | 12.48 |  |  |  |  |
Forfeited | (421) |  |  | $ | 12.06 |  |  |  |  |
Non-vested units as of December 31, 2022 | 9,717 |  |  | $ | 13.07 |  |  |  |  |
Granted | 4,762 |  |  | $ | 13.02 |  |  |  |  |
Vested | (3,610) |  |  | $ | 12.21 |  |  |  |  |
Forfeited | (836) |  |  | $ | 11.63 |  |  |  |  |
Non-vested units as of December 31, 2023 | 10,033 |  |  | $ | 13.37 |  |  |  |  |
Granted | 4,150 |  |  | $ | 14.32 |  |  |  |  |
Vested | (5,107) |  |  | $ | 13.07 |  |  |  |  |
Forfeited | (799) |  |  | $ | 13.74 |  |  |  |  |
Non-vested units as of December 31, 2024 | 8,277 |  |  | $ | 13.59 |  |  | 2.1 |  | $ | 78.0 |
Schedule of Equity Compensation Expenses | The following table summarizes information related to compensation expense recognized in the Company's Consolidated Statements of Operations related to the equity awards:
|  | Years ended December 31,
(in thousands) |  | 2024 |  | 2023 |  | 2022
Research and development expense |  | $ | 15,969 |  |  | $ | 21,470 |  |  | $ | 25,089 |
Selling, general, and administrative expense |  | 68,936 |  |  | 64,607 |  |  | 51,423 |
Total equity compensation expense |  | $ | 84,905 |  |  | $ | 86,077 |  |  | $ | 76,512 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Disclosure of the number and weighted-average grant date fair value for restricted stock and restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock and restricted stock units that were granted, vested, or forfeited during the year. + References No definition available. + Details
Name: | us-gaap_ScheduleOfSharebasedCompensationRestrictedStockAndRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration